Immunic Inc (IMUX)

Sep 30, 2026

Immunic CEO: “We want to understand MS patients better than anyone” - European Biotechnology Magazine

Sep 30, 2026

Sep 29, 2026

Immunic, Inc. Actuals & Estimates (HAN:10V) - TradingView

Sep 29, 2026

Sep 29, 2026

Pretax income of Immunic, Inc. – HAN:10V - TradingView

Sep 29, 2026

Sep 29, 2026

Immunic, Inc. Balance Sheet – HAN:10V - TradingView

Sep 29, 2026

Sep 29, 2026

Seven new Immunic employees get stock options tied to 196,350 shares - Stock Titan

Sep 29, 2026

Sep 28, 2026

Form 4 Immunic Inc For: 28 September By Investing.com - Investing.com Canada

Sep 28, 2026

Sep 27, 2026

Form 4 Immunic Inc For: 27 September - Investing.com India

Sep 27, 2026

Sep 27, 2026

Form 4 Immunic Inc For: 27 September By Investing.com - Investing.com Canada

Sep 27, 2026

Sep 25, 2026

Immunic Inc (NASDAQ: IMUX) Share Price, IMUX Stock News, IMUX Share Price & Updates - kalkine.ca

Sep 25, 2026

Sep 25, 2026

Immunic, Inc. (IMUX) Options Chain - Yahoo! Finance Canada

Sep 25, 2026

Sep 24, 2026

Why Did IMUX Stock Surge 33% Pre-Market Today? - Stocktwits

Sep 24, 2026

Sep 24, 2026

Immunic Inc (10V.HM) cash flow - uk.finance.yahoo.com

Sep 24, 2026

Sep 24, 2026

Immunic (IMUX) Short Interest & Short Float | Updated Sep 2026 - MarketBeat

Sep 24, 2026

Sep 23, 2026

Immunic Inc (10V.HM) recent insider transactions - Yahoo Finance UK

Sep 23, 2026

Sep 23, 2026

10V.HM Interactive Stock Chart | Immunic Inc. R Stock - Yahoo Finance

Sep 23, 2026

Sep 20, 2026

Epstein-Barr Virus Market Set to Witness Growth with Emerging Immunotherapies and Vaccine Pipeline by 2036 – DelveInsight | Atara Biotherapeutics, Pierre Fabre Laboratories, Immunic Therapeutics - Barchart.com

Sep 20, 2026

Sep 19, 2026

H.C. Wainwright Maintains Immunic(IMUX.US) With Buy Rating, Maintains Target Price $22 - Moomoo

Sep 19, 2026

Sep 18, 2026

Director at Immunic (IMUX) gets options at $10.12 a share - Stock Titan

Sep 18, 2026

Sep 18, 2026

New option grant tied to Immunic (IMUX) director - Stock Titan

Sep 18, 2026

Sep 18, 2026

Roth MKM Maintains Immunic(IMUX.US) With Buy Rating, Raises Target Price to $29 - Moomoo

Sep 18, 2026

Sep 16, 2026

Immunic Appoints Chitrang Davé Chief Data and Digital Officer - CDO Magazine

Sep 16, 2026

Sep 12, 2026

Immunic announces resignation of director Duane Nash and board size reduction By Investing.com - Investing.com Australia

Sep 12, 2026

Sep 11, 2026

Immunic Director Dr. Duane Nash Resigns; Board Cut to Nine Members - minichart.com.sg

Sep 11, 2026

Sep 11, 2026

Form 8K Immunic Inc For: 11 September By Investing.com - Investing.com South Africa

Sep 11, 2026

Sep 11, 2026

Immunic announces resignation of director Duane Nash and board size reduction - Investing.com

Sep 11, 2026

Sep 11, 2026

Dr. Duane Nash resigns from Immunic board; board reduced to nine members - TradingView

Sep 11, 2026

Sep 11, 2026

symbol__ Stock Quote Price and Forecast - CNN

Sep 11, 2026

Sep 10, 2026

H.C. Wainwright reiterates Immunic stock rating on MS drug progress By Investing.com - Investing.com Nigeria

Sep 10, 2026

Sep 10, 2026

Immunic, Inc. (IMUX) Presents at EFMC Medicinal Chemistry 2026 BaselSlideshow (NASDAQ:IMUX) 2026-09-10 - Seeking Alpha

Sep 10, 2026

Sep 10, 2026

IMUX Reiterated by Wedbush -- Price Target Maintained at $45 - GuruFocus

Sep 10, 2026

Sep 10, 2026

Why Is Immunic (NASDAQ:IMUX) Advancing Its MS Drug Program? - Kalkine Media

Sep 10, 2026

Sep 10, 2026

Stifel reiterates Immunic stock rating on MS drug potential - Investing.com

Sep 10, 2026

Sep 10, 2026

Stifel reiterates Immunic stock rating on MS drug potential By Investing.com - Investing.com Canada

Sep 10, 2026

Sep 10, 2026

IMUX Reiterates by HC Wainwright & Co. -- Price Target Maintained at $22 - GuruFocus

Sep 10, 2026

Sep 09, 2026

Immunic, Inc. R&D Day Transcript - GuruFocus

Sep 09, 2026

Sep 09, 2026

IMUX: Pivotal Phase 3 data for vidofludimus calcium in relapsing MS expected by end of 2026 - TradingView

Sep 09, 2026

Sep 09, 2026

Immunic (NASDAQ: IMUX) plans Sept. 9 relapsing MS R&D webinar - stocktitan.net

Sep 09, 2026

Sep 09, 2026

Immunic hosts RMS R&D Day webinar, presents vidofludimus calcium program and forward-looking plans - TradingView

Sep 09, 2026

Sep 08, 2026

Immunic lines up three July investor events in Boston and SF - stocktitan.net

Sep 08, 2026

Sep 02, 2026

Small cap wrap: Immunic, Midnight Sun Mining, Purepoint Uranium... - proactiveinvestors.com.au

Sep 02, 2026

Sep 02, 2026

Immunic to host virtual R&D day on relapsing MS ahead of Phase 3 trial results - Pluang

Sep 02, 2026

Sep 02, 2026

Immunic to Host Virtual Relapsing Multiple Sclerosis R&D Day on September 9, 2026 - Investing News Network

Sep 02, 2026

Sep 02, 2026

Immunic to host virtual relapsing MS R&D Day on September 9 - Yahoo Finance

Sep 02, 2026

Sep 02, 2026

EQS-News: Immunic to Host Virtual Relapsing Multiple Sclerosis R&D Day on September 9, 2026boerse.de - boerse.de

Sep 02, 2026

Sep 01, 2026

Immunic names Chitrang Davé chief data and digital officer - thepharmaletter.com

Sep 01, 2026

Sep 01, 2026

Immunic Appoints Chitrang Davé as Chief Data and Digital Officer - Investing News Network

Sep 01, 2026

Sep 01, 2026

Immunic appoints Chitrang Davé as chief data and digital officer - Yahoo Finance

Sep 01, 2026